Tumor Metabolome Targeting and Drug Development

Tumor Metabolome Targeting and Drug Development

EnglishHardbackPrint on demand
Springer-Verlag New York Inc.
EAN: 9781461495444
Print on demand
Delivery on Wednesday, 3. of July 2024
€146.49
Common price €162.77
Discount 10%
pc
Do you want this product today?
Oxford Bookshop Banská Bystrica
not available
Oxford Bookshop Bratislava
not available
Oxford Bookshop Košice
not available

Detailed information

In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism.

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate. However, the metabolism of malignant cells generally varies from that of normal cells. These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mitochondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect--these topics and more are discussed in this volume.

EAN 9781461495444
ISBN 146149544X
Binding Hardback
Publisher Springer-Verlag New York Inc.
Publication date January 9, 2014
Pages 198
Language English
Dimensions 235 x 155
Country United States
Readership Professional & Scholarly
Illustrations 12 Illustrations, color; 10 Illustrations, black and white; VIII, 198 p. 22 illus., 12 illus. in color.
Editors Kanner Steven
Series Cancer Drug Discovery and Development